Ignite Creation Date:
2025-12-25 @ 1:02 AM
Ignite Modification Date:
2025-12-25 @ 11:16 PM
Study NCT ID:
NCT06707493
Status:
RECRUITING
Last Update Posted:
2025-10-17
First Post:
2024-11-23
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Ivosidenib as Post-HSCT Maintenance for AML
Sponsor:
Massachusetts General Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-12-08
Start Date Type:
ESTIMATED
Primary Completion Date:
2028-01-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-01-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-11-23
First Submit QC Date:
None
Study First Post Date:
2024-11-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-15
Last Update Post Date:
2025-10-17
Last Update Post Date Type:
ESTIMATED